Next Generation Pharmaceutical Impactor: A New Impactor for Pharmaceutical Inhaler Testing. Part III. Extension of Archival Calibration to 15 L/min-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Next Generation Pharmaceutical Impactor: A New Impactor for Pharmaceutical Inhaler Testing. Part III. Extension of Archival Calibration to 15 L/min

Published:2004-12 Issue:4 Volume:17 Page:335-343
ISSN:0894-2684
Container-title:Journal of Aerosol Medicine
language:en
Short-container-title:Journal of Aerosol Medicine

Author:

Marple Virgil A.¹,Olson Bernard A.¹,Santhanakrishnan Kumaragovindhan¹,Roberts Daryl L.²,Mitchell Jolyon P.³,Hudson-Curtis Buffy L.⁴

Affiliation:

1. Particle Calibration Laboratory, Mechanical Engineering Department, University of Minnesota, Minneapolis, Minnesota.

2. MSP Corporation, Shoreview, Minnesota.

3. Trudell Medical International, London, Ontario, Canada.

4. Statistical Sciences, GlaxoSmithKline Inc., Research Triangle Park, North Carolina.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pulmonary and Respiratory Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/jam.2004.17.335

Reference14 articles.

1. Next Generation Pharmaceutical Impactor (A New Impactor for Pharmaceutical Inhaler Testing). Part I: Design

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Particle size distribution of viable nebulized bacteriophage for the treatment of multi-drug resistant Pseudomonas aeruginosa;Respiratory Medicine and Research;2024-11

2. Towards More Precise Targeting of Inhaled Aerosols to Different Areas of the Respiratory System;Pharmaceutics;2024-01-10

3. Amorphous nasal powder advanced performance: in vitro/ex vivo studies and correlation with in vivo pharmacokinetics;Journal of Pharmaceutical Investigation;2023-09

4. Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles;Bioengineering & Translational Medicine;2023-08-21

5. Good Practices for the Laboratory Performance Testing of Aqueous Oral Inhaled Products (OIPs): an Assessment from the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS);AAPS PharmSciTech;2023-03-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3